Form 8-K - Current report:
SEC Accession No. 0001437749-22-001821
Filing Date
2022-01-28
Accepted
2022-01-28 08:00:16
Documents
17
Period of Report
2022-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20220118_8k.htm   iXBRL 8-K 42504
2 EXHIBIT 10.2 ex_325548.htm EX-10.2 43839
3 EXHIBIT 10.6 ex_325549.htm EX-10.6 15879
4 EXHIBIT 99.1 ex_329098.htm EX-99.1 15362
9 logo01.jpg GRAPHIC 9343
  Complete submission text file 0001437749-22-001821.txt   286208

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nby-20220124.xsd EX-101.SCH 3585
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20220124_def.xml EX-101.DEF 11421
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20220124_lab.xml EX-101.LAB 15310
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20220124_pre.xml EX-101.PRE 11581
11 EXTRACTED XBRL INSTANCE DOCUMENT nby20220118_8k_htm.xml XML 2565
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 22565350
SIC: 2834 Pharmaceutical Preparations